We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline include... Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN). Show more
Selection of EB-003 based on research indicating its non-hallucinogenic, anxiolytic and anti-depressant properties Enveric Biosciences (NASDAQ: ENVB) (āEnvericā or the āCompanyā), a...
Presentation showcases the profile of EB-003, a non-hallucinogenic, neuroplastogenic DMT analog, which has shown positive outcomes in animal models of anxiety and depression Enveric Biosciences...
Enveric Biosciences (NASDAQ: ENVB) (āEnvericā), a biotechnology company dedicated to the development of novel neuroplastogens for the treatment of neuropsychiatric disorders, today announced that...
Enveric and Aries recently announced a Licensing Agreement for patented topical product aimed at treating radiation dermatitis, which impacts approximately two million cancer patients per year...
Prioritized EB-003 as lead development candidate. EB-003 is a novel, non-hallucinogenic neuroplastogenic molecule designed to treat severe mental health disorders Announced preclinical results...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0065 | 1.51162790698 | 0.43 | 0.449 | 0.41 | 49609 | 0.42460788 | CS |
4 | -0.0825 | -15.8959537572 | 0.519 | 0.52 | 0.41 | 116019 | 0.48049708 | CS |
12 | -0.0633 | -12.6650660264 | 0.4998 | 0.77 | 0.41 | 1129935 | 0.56343691 | CS |
26 | -0.4735 | -52.032967033 | 0.91 | 1.03 | 0.41 | 800318 | 0.66707504 | CS |
52 | -1.7435 | -79.9770642202 | 2.18 | 2.92 | 0.41 | 1502813 | 1.17949593 | CS |
156 | -1.5335 | -77.8426395939 | 1.97 | 14.87 | 0.1551 | 1393281 | 1.70706267 | CS |
260 | -5.5635 | -92.725 | 6 | 14.87 | 0.1551 | 1922216 | 2.50223744 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions